1. Home
  2. ARQT vs AGYS Comparison

ARQT vs AGYS Comparison

Compare ARQT & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$28.33

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$120.99

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
AGYS
Founded
2016
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ARQT
AGYS
Price
$28.33
$120.99
Analyst Decision
Strong Buy
Buy
Analyst Count
7
6
Target Price
$24.83
$142.20
AVG Volume (30 Days)
2.0M
155.8K
Earning Date
10-28-2025
01-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.86
Revenue
$317,929,000.00
$299,809,000.00
Revenue This Year
$85.51
$16.75
Revenue Next Year
$30.74
$17.11
P/E Ratio
N/A
$141.15
Revenue Growth
129.21
17.77
52 Week Low
$11.13
$63.71
52 Week High
$31.77
$145.25

Technical Indicators

Market Signals
Indicator
ARQT
AGYS
Relative Strength Index (RSI) 51.12 45.32
Support Level $27.55 $119.77
Resistance Level $28.90 $123.40
Average True Range (ATR) 1.15 3.71
MACD -0.55 -0.72
Stochastic Oscillator 18.58 12.77

Price Performance

Historical Comparison
ARQT
AGYS

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About AGYS Agilysys Inc.

Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.

Share on Social Networks: